Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5183617
Max Phase: Preclinical
Molecular Formula: C41H57FN10O6S2
Molecular Weight: 869.10
Associated Items:
ID: ALA5183617
Max Phase: Preclinical
Molecular Formula: C41H57FN10O6S2
Molecular Weight: 869.10
Associated Items:
Canonical SMILES: CC(C)C(OC(=O)C(C)(C)C)n1nnnc1CCCNC(=S)NCCCC[C@H](NS(=O)(=O)c1cccc(F)c1)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)NC1CCC1
Standard InChI: InChI=1S/C41H57FN10O6S2/c1-26(2)38(58-39(55)41(3,4)5)52-35(48-50-51-52)20-12-22-44-40(59)43-21-9-8-19-33(49-60(56,57)30-16-10-13-28(42)24-30)36(53)47-34(37(54)46-29-14-11-15-29)23-27-25-45-32-18-7-6-17-31(27)32/h6-7,10,13,16-18,24-26,29,33-34,38,45,49H,8-9,11-12,14-15,19-23H2,1-5H3,(H,46,54)(H,47,53)(H2,43,44,59)/t33-,34-,38?/m0/s1
Standard InChI Key: LXEYBSPTUFFVNQ-LHWGYSBPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 869.10 | Molecular Weight (Monoisotopic): 868.3888 | AlogP: 4.35 | #Rotatable Bonds: 21 |
Polar Surface Area: 214.12 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 6 |
#RO5 Violations: 3 | HBA (Lipinski): 16 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 9.32 | CX Basic pKa: | CX LogP: 5.71 | CX LogD: 5.71 |
Aromatic Rings: 4 | Heavy Atoms: 60 | QED Weighted: 0.04 | Np Likeness Score: -1.19 |
1. Fiorentino F, Castiello C, Mai A, Rotili D.. (2022) Therapeutic Potential and Activity Modulation of the Protein Lysine Deacylase Sirtuin 5., 65 (14.0): [PMID:35802779] [10.1021/acs.jmedchem.2c00687] |
Source(1):